About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

HISAMITSU PHARMACEUTICAL CO.,INC.(4530) Summary

4530
TSE Prime
HISAMITSU PHARMACEUTICAL CO.,INC.
4,100
JPY
-19
(-0.46%)
Dec 23, 3:30 pm JST
26.18
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
19.0
PBR
1.10
Yield
2.20%
Margin Trading Ratio
3.06
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
4,079 JPY 26.05 USD
Previous Close Dec 20
4,119 JPY 26.25 USD
High Dec 23, 9:00 am
4,133 JPY 26.40 USD
Low Dec 23, 9:16 am
4,077 JPY 26.05 USD
Volume
83,200
Trading Value
0.34B JPY 2.18M USD
VWAP
4105.88 JPY 26.22 USD
Minimum Trading Value
410,000 JPY 2,618 USD
Market Cap
0.35T JPY 2.24B USD
Number of Trades
403
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
Slightly High
1-Year Average
644
1-Year High Jan 12, 2024
3,140
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 7,900 30,800 3.90
Dec 6, 2024 9,300 35,900 3.86
Nov 29, 2024 10,100 38,900 3.85
Nov 22, 2024 12,300 37,600 3.06
Nov 15, 2024 15,200 34,600 2.28
Company Profile
HISAMITSU PHARMACEUTICAL CO.,INC. is the market leader in anti-inflammatory analgesic patches, with its "Salonpas" brand being widely recognized. The company is strengthening its presence overseas, particularly in the United States and China.
Sector
Pharmaceuticals